Caesars Entertainment, Inc. (CZR)

Lumos Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	982	866	1,005	1,038	1,070	1,776
Short-Term Investments	-	-	-	-	-	10
Cash & Short-Term Investments	982	866	1,005	1,038	1,070	1,786
Cash Growth	18.31%	-13.83%	-3.18%	-2.99%	-40.09%	711.82%
Accounts Receivable	296	470	608	611	472	342
Other Receivables	191	-	-	-	-	44
Receivables	487	470	608	611	472	386
Inventory	44	45	46	59	42	44
Prepaid Expenses	330	271	264	263	290	243
Restricted Cash	85	95	122	131	319	2,021
Other Current Assets	-	-	-	-	3,771	1,583
Total Current Assets	1,928	1,747	2,045	2,102	5,964	6,063
Property, Plant & Equipment	14,646	15,416	15,378	15,237	15,263	15,192
Long-Term Investments	111	131	157	94	158	173
Goodwill	10,601	10,601	10,990	11,004	11,076	9,864
Other Intangible Assets	4,068	4,133	4,523	4,714	4,920	4,283
Long-Term Deferred Tax Assets	68	62	47	-	-	-
Other Long-Term Assets	1,056	500	226	376	650	810
Total Assets	32,478	32,590	33,366	33,527	38,031	36,385
Accounts Payable	263	296	408	314	254	167
Accrued Expenses	1,966	845	1,017	1,025	1,176	742
Current Portion of Long-Term Debt	110	109	65	108	70	67
Current Portion of Leases	-	21	23	50	49	53
Current Income Taxes Payable	-	205	202	195	183	172
Current Unearned Revenue	-	592	749	747	614	251
Other Current Liabilities	-	204	226	229	2,951	1,061
Total Current Liabilities	2,339	2,272	2,690	2,668	5,297	2,513
Long-Term Debt	12,023	12,033	12,224	12,659	13,750	14,163
Long-Term Leases	13,907	13,615	13,487	13,320	13,150	12,811
Long-Term Deferred Tax Liabilities	90	130	102	987	1,111	1,166
Other Long-Term Liabilities	-	164	143	142	182	698
Total Liabilities	28,359	28,214	28,646	29,776	33,490	31,351
Additional Paid-In Capital	6,796	6,862	7,001	6,953	6,877	6,382
Retained Earnings	-2,998	-2,801	-2,523	-3,309	-2,410	-1,391
Treasury Stock	-	-	-23	-23	-23	-9
Comprehensive Income & Other	98	96	97	92	36	34
Total Common Equity	3,896	4,157	4,552	3,713	4,480	5,016
Minority Interest	223	219	168	38	61	18
Shareholders' Equity	4,119	4,376	4,720	3,751	4,541	5,034
Total Liabilities & Equity	32,478	32,590	33,366	33,527	38,031	36,385
Total Debt	26,040	25,778	25,799	26,137	27,019	27,094
Net Cash (Debt)	-25,058	-24,912	-24,794	-25,099	-25,949	-25,308
Net Cash Per Share	-118.20	-115.87	-114.79	-117.29	-122.98	-194.68
Filing Date Shares Outstanding	207.99	212.01	216.3	215.18	214.12	208.28
Total Common Shares Outstanding	208	211.33	215.8	214.67	213.78	208.05
Working Capital	-411	-525	-645	-566	667	3,550
Book Value Per Share	18.73	19.67	21.09	17.30	20.96	24.11
Tangible Book Value	-10,773	-10,577	-10,961	-12,005	-11,516	-9,131
Tangible Book Value Per Share	-51.79	-50.05	-50.79	-55.92	-53.87	-43.89
Land	2,058	2,059	2,088	2,092	2,125	2,187
Buildings	15,108	14,866	13,543	13,094	12,433	12,059
Machinery	3,025	2,880	2,409	2,054	1,650	1,419
Construction In Progress	216	167	762	351	395	118

Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q